8-arylxanthines

Organic compounds -- part of the class 532-570 series – Organic compounds – Chalcogen bonded directly to ring carbon of the purine ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544272, 544273, 514263, 514265, C07D23936, A61K 3152

Patent

active

047835303

ABSTRACT:
1,3-alkylsubstituted-8-(3,4-,3- or 4-substituted phenyl)xanthines and pharmaceutically acceptable salts of such compounds are disclosed. The 3-substituents are hydrogen, dimethylaminomethyl, or 2,3-dihydroxypropyloxy. The 4-substituents are selected from hydroxy, cyano, --NHCON(R.sub.5).sub.2, --C(.dbd.NH)N(R.sub.5).sub.2, --NH--C(.dbd.NH)N(R.sub.5).sub.2, with each R.sub.5 independently being hydrogen or an alkyl group of one to three carbons and provided that when the 3-substituent is hydrogen the 4-substituent is not hydroxy or hydrogen.
The compounds are potent adenosine receptor antagonists having relatively low lipophilicity. The compounds are intended for use as bronchodilators and cardiotonics.

REFERENCES:
patent: 4593095 (1986-06-01), Snyder et al.
Copy provided in parent case.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

8-arylxanthines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 8-arylxanthines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-arylxanthines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-464630

All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.